Mau H, Heller K
Z Exp Chir. 1982 Jul;15(4):251-5.
Pressing need of selectively vesically or spinally acting neuropharmacons exists for patients with neurogenic disturbances of the function of the urinary bladder especially for children with myelomeningocele. The medicament MICTONORM a peripherally effective anticholinergic drug was tested in healthy young pigs with reference to the effect on the storage volume of the bladder. Cystometrograms were recorded in the narcotised experimental animal before and after intravenous application of 0.5 mg MICTONORM per kg body mass. The average increase of the vesical capacity after the drug application amounted to 39.2% (dispersion 6.3 - 95.3%). The values of the vesical pressure showed a nonuniform behaviour. An effect in the afferent part of the vesical reflex arc comes into question for the pharmacon because of the type of action.
对于患有膀胱功能神经源性障碍的患者,尤其是患有脊髓脊膜膨出的儿童,迫切需要选择性作用于膀胱或脊髓的神经药物。药物米多卡胺(MICTONORM)是一种外周作用的抗胆碱能药物,针对其对膀胱储尿量的影响,在健康幼猪身上进行了测试。在麻醉的实验动物身上,静脉注射每千克体重0.5毫克米多卡胺前后记录膀胱内压图。用药后膀胱容量平均增加39.2%(离散度6.3 - 95.3%)。膀胱压力值表现出不一致的行为。由于该药物的作用类型,其对膀胱反射弧传入部分产生作用是有可能的。